Medical Hypotheses
Volume 61, Issue 3 , Pages 335-339, September 2003

Estrogen agonists/antagonists may down-regulate growth hormone signaling in hepatocytes–An explanation for their impact on IGF-I, IGFBP-1, and lipoprotein(a)

  • Mark F McCarty

      Affiliations

    • Corresponding Author InformationCorrespondence to: Mark F. McCarty, Present address: NutriGuard Research, 1051 Hermes Ave., Encinitas, CA 92024, USA

Pantox Laboratories, San Diego, CA 92109, USA

Received 27 July 2001; accepted 19 December 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0306-9877(02)00215-3

doi:10.1016/S0306-9877(02)00215-3

Medical Hypotheses
Volume 61, Issue 3 , Pages 335-339, September 2003

Article Tools